Non-viral vectors have emerged as an effective and safe delivery vehicle for genetically-modified therapies; the growing interest in these vectors has further resulted in an adjacent demand for versatile transfection reagents and systems LONDON, Sept. 20, 2023 /PRNewswire/ — Roots…